Deep brain stimulation for Parkinson disease an expert consensus and review of key issues

Archives of Neurology

Volumn 68, Issue 2, 2011, Pages 165-171

  Bronstein, Jeff M ^a   Tagliati, Michele ^b   Alterman, Ron L ^b   Lozano, Andres M ^c   Volkmann, Jens ^d   Stefani, Alessandro ^e   Horak, Fay B ^f   Okun, Michael S ^g   Foote, Kelly D ^g   Krack, Paul ^h   Pahwa, Rajesh ⁱ   Henderson, Jaimie M ^j   Hariz, Marwan I ^k   Bakay, Roy A ^l   Rezai, Ali ^m   Marks Jr , William J ⁿ   Moro, Elena ^c   Vitek, Jerrold L ^m   Weaver, Frances M ^o   Gross, Robert E ^p   DeLong, Mahlon R ^p   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g UNIVERSITY OF FLORIDA   (United States)

^h GRENOBLE UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^j STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^l RUSH MEDICAL COLLEGE   (United States)

^m LERNER RESEARCH INSTITUTE   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o HINES VA HOSPITAL   (United States)

^p EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ABLATION THERAPY; APATHY; BRAIN DEPTH STIMULATION; BRAIN HEMORRHAGE; BRAIN SURGERY; COGNITIVE DEFECT; COMPUTER; COMPUTER PROGRAM; CONSENSUS DEVELOPMENT; DATA EXTRACTION; DEPRESSION; DYSKINESIA; EXECUTIVE FUNCTION; GAIT; HEALTH CARE PERSONNEL; HUMAN; IMPULSIVENESS; INFECTION; INFORMATION RETRIEVAL; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARKINSON DISEASE; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SPEECH ANALYSIS; STEREOTAXIC SURGERY; STROKE; SUBTHALAMIC NUCLEUS; SURGEON; TREMOR; WORKSHOP;

DEEP BRAIN STIMULATION; GLOBUS PALLIDUS; HUMANS; NEUROSURGICAL PROCEDURES; PARKINSON DISEASE; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; STEREOTAXIC TECHNIQUES; SUBTHALAMIC NUCLEUS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 79951526730     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.260     Document Type: Review

References (60)

1. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science. 1990;249(4975):1436-1438.
2. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990;13(7):281-285. (Pubitemid 20193459)
3. Aziz TZ, Peggs D, Sambrook MA, Crossman AR. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord. 1991;6(4):288-292.
4. Okun MS, Tagliati M, Pourfar M, et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol. 2005;62(8):1250-1255. (Pubitemid 41168352)
5. Morgante L, Morgante F, Moro E, et al. How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? results of a questionnaire. Parkinsonism Relat Disord. 2007;13(8):528-531. (Pubitemid 350110555)
6. Moro E, Volkmann J, König IR, et al. Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. Neurology. 2008;70(14):1186-1191. (Pubitemid 351482570)
7. Schüpbach M, Lohmann E, Anheim M, et al. Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations. Mov Disord. 2007;22(1):119-122.
8. Lohmann E, Welter ML, Fraix V, et al; French Parkinson's Disease Genetics study group. Are parkin patients particularly suited for deep-brain stimulation? Mov Disord. 2008;23(5):740-743.
9. Shih LC, Tarsy D. Deep brain stimulation for the treatment of atypical parkinsonism. Mov Disord. 2007;22(15):2149-2155.
10. Weaver FM, Follett K, Stern M, et al; CSP 468 Study Group. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009;301(1):63-73.
11. Lang AE, Houeto JL, Krack P, et al. Deep brain stimulation: preoperative issues. Mov Disord. 2006;21(suppl 14):S171-S196. (Pubitemid 44028281)
12. Saint-Cyr JA, Trépanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain. 2000;123(pt 10):2091-2108.
13. Ory-Magne F, Brefel-Courbon C, Simonetta-Moreau M, et al. Does ageing influence deep brain stimulation outcomes in Parkinson's disease? Mov Disord. 2007;22(10):1457-1463. (Pubitemid 47280632)
14. Russmann H, Ghika J, Villemure JG, et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology. 2004;63(10):1952-1954. (Pubitemid 39532401)
15. Derost PP, Ouchchane L, Morand D, et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology. 2007;68(17):1345-1355. (Pubitemid 46659085)
16. Sansur CA, Frysinger RC, Pouratian N, et al. Incidence of symptomatic hemorrhage after stereotactic electrode placement. J Neurosurg. 2007;107(5):998-1003. (Pubitemid 350255215)
17. Schüpbach WM, Maltête D, Houeto JL, et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology. 2007;68(4):267-271. (Pubitemid 46148337)
18. Charles PD, Van Blercom N, Krack P, et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology. 2002;59(6):932-934.
19. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006;21(suppl 14):S290-S304. (Pubitemid 44028288)
20. Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain. 2008;131(pt 10):2720-2728.
21. Blomstedt P, Hariz MI. Hardware-related complications of deep brain stimulation: a ten year experience. Acta Neurochir (Wien). 2005;147(10):1061- 1064. (Pubitemid 41374431)
22. Videnovic A, Metman LV. Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting. Mov Disord. 2008;23(3):343-349.
23. Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med. 2001;345(13):956-963.
24. Hamani C, Lozano AM. Hardware-related complications of deep brain stimulation: a review of the published literature. Stereotact Funct Neurosurg. 2006;84(5-6):248-251. (Pubitemid 44763204)
25. Deuschl G, Schade-Brittinger C, Krack P, et al; German Parkinson Study Group, Neurostimulation Section. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006;355(9):896-908. (Pubitemid 44315982)
26. Rezai AR, Phillips M, Baker KB, et al. Neurostimulation system used for deep brain stimulation (DBS): MR safety issues and implications of failing to follow safety recommendations. Invest Radiol. 2004;39(5):300-303. (Pubitemid 38520664)
27. Rezai AR, Baker KB, Tkach JA, et al. Is magnetic resonance imaging safe for patients with neurostimulation systems used for deep brain stimulation? Neurosurgery. 2005;57(5):1056-1062.
28. Phillips MD, Baker KB, Lowe MJ, et al. Parkinson disease: pattern of functional MR imaging activation during deep brain stimulation of subthalamic nucleus: initial experience. Radiology. 2006;239(1):209-216.
29. Baker KB, Tkach J, Hall JD, Nyenhuis JA, Shellock FG, Rezai AR. Reduction of magnetic resonance imaging-related heating in deep brain stimulation leads using a lead management device. Neurosurgery. 2005;57(4)(suppl):392-397.
30. Bhidayasiri R, Bronstein JM, Sinha S, et al. Bilateral neurostimulation systems used for deep brain stimulation: in vitro study of MRI-related heating at 1.5 T and implications for clinical imaging of the brain. Magn Reson Imaging. 2005;23(4):549-555. (Pubitemid 40779241)
31. Larson PS, Richardson RM, Starr PA, Martin AJ. Magnetic resonance imaging of implanted deep brain stimulators: experience in a large series. Stereotact Funct Neurosurg. 2008;86(2):92-100. (Pubitemid 351341535)
32. Tagliati M, Jankovic J, Pagan F, Susatia F, Isaias IU, Okun MS; National Parkinson Foundation DBS Working Group. Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage. 2009;47(suppl 2):T53-T57.
33. Henderson JM, Tkach J, Phillips M, Baker K, Shellock FG, Rezai AR. Permanent neurological deficit related to magnetic resonance imaging in a patient with implanted deep brain stimulation electrodes for Parkinson's disease: case report. Neurosurgery. 2005;57(5):E1063.
34. Moreau C, Defebvre L, Destée A, et al. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology. 2008;71(2):80-84.
35. Forsaa EB, Larsen JP, Wentzel-Larsen T, Herlofson K, Alves G. Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord. 2008;23(10):1420-1427.
36. Pickering RM, Grimbergen YA, Rigney U, et al. A meta-analysis of six prospective studies of falling in Parkinson's disease. Mov Disord. 2007;22(13):1892-1900. (Pubitemid 350134202)
37. Horak FB, Frank J, Nutt J. Effects of dopamine on postural control in parkinsonian subjects: scaling, set, and tone. J Neurophysiol. 1996;75(6):2380-2396. (Pubitemid 26200633)
38. Lyoo CH, Aalto S, Rinne JO, et al. Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait. Mov Disord. 2007;22(15):2176-2182.
39. Follett KA, Weaver FM, Stern M, et al; CSP 468 Study Group. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med. 2010;362(22):2077-2091.
40. Hälbig TD, Tse W, Frisina PG, et al. Subthalamic deep brain stimulation and impulse control in Parkinson's disease. Eur J Neurol. 2009;16(4):493-497.
41. Smeding HM, Speelman JD, Koning-Haanstra M, et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology. 2006;66(12):1830-1836. (Pubitemid 44049811)
42. Houeto JL, Mesnage V, Mallet L, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry. 2002;72(6):701-707. (Pubitemid 34557009)
43. Schüpbach M, Gargiulo M, Welter ML, et al. Neurosurgery in Parkinson disease: a distressed mind in a repaired body? Neurology. 2006;66(12):1811- 1816. (Pubitemid 44049808)
44. Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science. 2007;318(5854):1309-1312. (Pubitemid 350172897)
45. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain. 2005;128(pt 10):2240-2249. (Pubitemid 41407964)
46. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 2003;349(20):1925-1934. (Pubitemid 37409709)
47. Volkmann J, Albanese A, Kulisevsky J, et al. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord. 2009;24(8):1154-1161.
48. Volkmann J, Allert N, Voges J, Sturm V, Schnitzler A, Freund HJ. Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol. 2004;55(6):871-875. (Pubitemid 38702583)
49. Schüpbach WM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry. 2005;76(12):1640-1644. (Pubitemid 41697626)
50. Hariz MI, Krack P, Alesch F, et al. Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J Neurol Neurosurg Psychiatry. 2008;79(6):694-699. (Pubitemid 351829444)
51. Gervais-Bernard H, Xie-Brustolin J, Mertens P, et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up. J Neurol. 2009;256(2):225-233.
52. Houeto JL, Bejjani PB, Damier P, et al. Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD. Neurology. 2000;55(5):728-730.
53. Weaver F, Follett K, Hur K, Ippolito D, Stern M. Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. J Neurosurg. 2005;103(6):956-967. (Pubitemid 43194543)
54. Nakamura K, Christine CW, Starr PA, Marks WJ Jr. Effects of unilateral subthalamic and pallidal deep brain stimulation on fine motor functions in Parkinson's disease. Mov Disord. 2007;22(5):619-626. (Pubitemid 46800129)
55. Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol. 2005;62(4):554-560. (Pubitemid 40489885)
56. Zahodne LB, Okun MS, Foote KD, et al. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J Neurol. 2009;256(8):1321-1329.
57. Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol. 2009;65(5):586-595.
58. Starr PA, Vitek JL, Bakay RA. Ablative surgery and deep brain stimulation for Parkinson's disease. Neurosurgery. 1998;43(5):989-1015. (Pubitemid 128723296)
59. Alvarez L, Macias R, Pavón N, et al. Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months. J Neurol Neurosurg Psychiatry. 2009;80(9):979-985.
60. Gross RE. What happened to posteroventral pallidotomy for Parkinson's disease and dystonia? Neurotherapeutics. 2008;5(2):281-293. (Pubitemid 351446216)